Search clinical trials for: Loncastuximab Tesirine and Durvalumab
Total 777 results
-
ADC Therapeutics S.A.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell LymphomaSpain, United States
-
University of MiamiADC Therapeutics S.A.RecruitingMarginal Zone LymphomaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States
-
ADC Therapeutics S.A.No longer availableRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
-
M.D. Anderson Cancer CenterRecruitingLymphoma | Large B-cell LymphomaUnited States
-
ADC Therapeutics S.A.RecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell LymphomaTaiwan, Korea, Republic of, United States, Brazil
-
Mayur NarkhedeADC Therapeutics S.A.RecruitingChronic Lymphocytic LeukemiaUnited States
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell LymphomaSpain, United States, Italy, Puerto Rico
-
ADC Therapeutics S.A.TerminatedDiffuse Large B-Cell Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, France, Italy, Belgium
-
University of WashingtonRecruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Refractory Mantle Cell Lymphoma | Recurrent Follicular... and other conditionsUnited States
-
ADC Therapeutics S.A.RecruitingB-Cell Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Spain, Italy, United Kingdom, Belgium, Czechia
-
ADC Therapeutics S.A.TerminatedRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
ADC Therapeutics S.A.CompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | Burkitt's Lymphoma | Lymphoma, Marginal ZoneUnited Kingdom, United States, Italy
-
ADC Therapeutics S.A.TerminatedAcute Lymphoblastic LeukemiaUnited States
-
ADC Therapeutics S.A.RecruitingRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaJapan, Belgium, France, Italy, Spain, United Kingdom, United States, Israel, Hungary, Brazil, Switzerland, Poland, Canada, Puerto Rico, Czechia, Netherlands, China, Mexico, Argentina, Chile, Turkey
-
Medical College of WisconsinRecruitingB-cell Lymphoma | Burkitt LymphomaUnited States
-
Brian HillRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly
-
Juan P. Alderuccio, MDADC Therapeutics S.A.RecruitingFollicular LymphomaUnited States
-
Shayna Sarosiek, MDADC Therapeutics S.A.Recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Albany Medical CollegeUnknownSarcoidosis | Hypercalcemia Due to SarcoidosisUnited States
-
StemcentrxCompletedSmall Cell Lung CarcinomaUnited States, Canada
-
AbbVieCompletedAdvanced Solid TumorsUnited States, Australia, Austria, Belgium, Canada, Finland, France, Japan, Spain, Taiwan
-
LENZ Therapeutics, IncORA, Inc.CompletedEye Diseases | Presbyopia | Miosis | Near VisionUnited States
-
AstraZenecaKappa SantéRecruiting
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Hark Kyun KimRecruiting
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Yonsei UniversityCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
ADC Therapeutics S.A.TerminatedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Pancreas Cancer | Colo-rectal Cancer | Triple-negative Breast Cancer | Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content | Head and Neck...United States, Belgium, United Kingdom
-
ETOP IBCSG Partners FoundationAstraZeneca AG SwitzerlandNot yet recruiting
-
AstraZenecaActive, not recruiting
-
Institut Claudius RegaudActive, not recruiting
-
AstraZenecaCompletedAdvanced Solid MalignanciesJapan
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingHepatocellular CarcinomaChina